CTRI/2021/04/033005已完成未知
Efficacy and Safety of Voglibose v/s Glimepiride in Combination with Metformin in Type-2 Diabetes: A Randomized Controlled Trial
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 73
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. NEWLY DIAGNOSED T2-DM WITH HbA1c between 7-11% or,
- •2. T2-DM PATIENT UNCONTROLLED ON METFORMIN 500MG BD (RBS >200 ON ATLEAST 3 OCASSIONS OR HbA1c between 7-11%).
排除标准
- •1. Type-1 DM PATIENTS
- •2. PREGNANCY & LACTATING WOMEN
- •3. PATIENTS WITH HEART FAILURE (NYHA CLASS 2-4)
- •4. PATIENTS WITH HISTORY OF CHRONIC KIDNEY
- •DISEASE (SERUM CREATININE > 1.5mg/dl)
- •5. PATINETS WITH HISTORY OF LIVER FAILURE
- •6. PATIENTS WITH HISTORY OF AUTOIMMUNE DISORDERS
- •7. PATIENTS WITH HISTORY OF COPD.
研究者
相似试验
已完成
不适用
Comparison of Remogliflozin with vildagliptin in the treatment of diabetesCTRI/2020/02/023120Maulana azad medical college
尚未招募
3 期
COMPARATIVE STUDY OF TREATMENT OF CHRONIC AND RECURRENT DERMATOPHYTOSIS - RANDOMIZED CLINICAL TRIACTRI/2023/05/053261Arulmozhi Rajan
已完成
4 期
Comparison of utility of Viladagliptin 50 mg tablet twice daily and metformin combination therapy with Vildagliptin 100 mg sustained release tablet once daily and metformin combination therapy in Indian patients with type 2 diabetes mellitus: A randomized open label phase IV clinical trialCTRI/2021/10/037574Dr Rudra Paul
招募中
不适用
Comparison of efficacy and safety of Vildagliptin and Teneligliptin in patients with Type 2 Diabetes MellitusCTRI/2017/02/007766jawaharlal nehru medical college and hospital160
已完成
不适用
A group comparison between gliclazide and glimepiride among type 2 diabetic patients using sitagliptin.JPRN-UMIN000003953Hokuriku Incretin-based Therapy Study Group (HINT Study Group)50